Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

IQV vs PRA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IQV
IQVIA Holdings Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$30.32B
5Y Perf.+19.5%
PRA
ProAssurance Corporation

Insurance - Property & Casualty

Financial ServicesNYSE • US
Market Cap$1.27B
5Y Perf.+78.3%

IQV vs PRA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IQV logoIQV
PRA logoPRA
IndustryMedical - Diagnostics & ResearchInsurance - Property & Casualty
Market Cap$30.32B$1.27B
Revenue (TTM)$16.63B$1.08B
Net Income (TTM)$1.39B$65M
Gross Margin26.1%25.5%
Operating Margin13.9%8.4%
Forward P/E14.1x21.8x
Total Debt$16.17B$435M
Cash & Equiv.$1.98B$36M

IQV vs PRALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IQV
PRA
StockMay 20May 26Return
IQVIA Holdings Inc. (IQV)100119.5+19.5%
ProAssurance Corpor… (PRA)100178.3+78.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: IQV vs PRA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IQV leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. ProAssurance Corporation is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IQV
IQVIA Holdings Inc.
The Income Pick

IQV carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 1.33
  • Rev growth 5.9%, EPS growth 4.7%, 3Y rev CAGR 4.2%
  • 166.5% 10Y total return vs PRA's -18.8%
Best for: income & stability and growth exposure
PRA
ProAssurance Corporation
The Insurance Pick

PRA is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.05, Low D/E 32.2%, current ratio 1.33x
  • Beta 0.05, current ratio 1.33x
  • Beta 0.05 vs IQV's 1.33, lower leverage
Best for: sleep-well-at-night and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthIQV logoIQV5.9% revenue growth vs PRA's -2.7%
ValueIQV logoIQVLower P/E (14.1x vs 21.8x)
Quality / MarginsIQV logoIQV8.3% margin vs PRA's 6.0%
Stability / SafetyPRA logoPRABeta 0.05 vs IQV's 1.33, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)IQV logoIQV+16.5% vs PRA's +7.2%
Efficiency (ROA)IQV logoIQV4.7% ROA vs PRA's 1.2%, ROIC 8.7% vs 3.2%

IQV vs PRA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IQVIQVIA Holdings Inc.
FY 2025
Research And Development Solutions
54.5%$8.9B
Technology And Analytics Solutions
40.6%$6.6B
Contract Sales And Medical Solutions
4.8%$788M
PRAProAssurance Corporation
FY 2025
Specialty Property and Casualty
77.5%$724M
Workers' Compensation Insurance Segment
17.6%$164M
Segregated Portfolio Cell Reinsurance
4.9%$46M

IQV vs PRA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIQVLAGGINGPRA

Income & Cash Flow (Last 12 Months)

IQV leads this category, winning 5 of 6 comparable metrics.

IQV is the larger business by revenue, generating $16.6B annually — 15.4x PRA's $1.1B. Profitability is closely matched — net margins range from 8.3% (IQV) to 6.0% (PRA). On growth, IQV holds the edge at +8.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIQV logoIQVIQVIA Holdings In…PRA logoPRAProAssurance Corp…
RevenueTrailing 12 months$16.6B$1.1B
EBITDAEarnings before interest/tax$3.5B$101M
Net IncomeAfter-tax profit$1.4B$65M
Free Cash FlowCash after capex$2.7B-$17M
Gross MarginGross profit ÷ Revenue+26.1%+25.5%
Operating MarginEBIT ÷ Revenue+13.9%+8.4%
Net MarginNet income ÷ Revenue+8.3%+6.0%
FCF MarginFCF ÷ Revenue+16.1%-1.6%
Rev. Growth (YoY)Latest quarter vs prior year+8.4%-2.0%
EPS Growth (YoY)Latest quarter vs prior year+15.0%+2.5%
IQV leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

IQV leads this category, winning 3 of 5 comparable metrics.

At 22.8x trailing earnings, IQV trades at a 8% valuation discount to PRA's 24.9x P/E. On an enterprise value basis, IQV's 13.0x EV/EBITDA is more attractive than PRA's 19.5x.

MetricIQV logoIQVIQVIA Holdings In…PRA logoPRAProAssurance Corp…
Market CapShares × price$30.3B$1.3B
Enterprise ValueMkt cap + debt − cash$44.5B$1.7B
Trailing P/EPrice ÷ TTM EPS22.79x24.86x
Forward P/EPrice ÷ next-FY EPS est.14.06x21.76x
PEG RatioP/E ÷ EPS growth rate0.56x
EV / EBITDAEnterprise value multiple12.97x19.46x
Price / SalesMarket cap ÷ Revenue1.86x1.16x
Price / BookPrice ÷ Book value/share4.67x0.94x
Price / FCFMarket cap ÷ FCF14.78x
IQV leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

IQV leads this category, winning 5 of 9 comparable metrics.

IQV delivers a 22.1% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $5 for PRA. PRA carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQV's 2.44x. On the Piotroski fundamental quality scale (0–9), IQV scores 4/9 vs PRA's 3/9, reflecting mixed financial health.

MetricIQV logoIQVIQVIA Holdings In…PRA logoPRAProAssurance Corp…
ROE (TTM)Return on equity+22.1%+5.0%
ROA (TTM)Return on assets+4.7%+1.2%
ROICReturn on invested capital+8.7%+3.2%
ROCEReturn on capital employed+11.0%+4.0%
Piotroski ScoreFundamental quality 0–943
Debt / EquityFinancial leverage2.44x0.32x
Net DebtTotal debt minus cash$14.2B$399M
Cash & Equiv.Liquid assets$2.0B$36M
Total DebtShort + long-term debt$16.2B$435M
Interest CoverageEBIT ÷ Interest expense3.10x4.53x
IQV leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PRA leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in PRA five years ago would be worth $9,679 today (with dividends reinvested), compared to $7,621 for IQV. Over the past 12 months, IQV leads with a +16.5% total return vs PRA's +7.2%. The 3-year compound annual growth rate (CAGR) favors PRA at 9.7% vs IQV's -2.0% — a key indicator of consistent wealth creation.

MetricIQV logoIQVIQVIA Holdings In…PRA logoPRAProAssurance Corp…
YTD ReturnYear-to-date-20.7%+2.5%
1-Year ReturnPast 12 months+16.5%+7.2%
3-Year ReturnCumulative with dividends-5.9%+32.0%
5-Year ReturnCumulative with dividends-23.8%-3.2%
10-Year ReturnCumulative with dividends+166.5%-18.8%
CAGR (3Y)Annualised 3-year return-2.0%+9.7%
PRA leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

PRA leads this category, winning 2 of 2 comparable metrics.

PRA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than IQV's 1.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRA currently trades 99.0% from its 52-week high vs IQV's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIQV logoIQVIQVIA Holdings In…PRA logoPRAProAssurance Corp…
Beta (5Y)Sensitivity to S&P 5001.33x0.05x
52-Week HighHighest price in past year$247.05$24.85
52-Week LowLowest price in past year$134.65$22.72
% of 52W HighCurrent price vs 52-week peak+72.3%+99.0%
RSI (14)Momentum oscillator 0–10058.548.4
Avg Volume (50D)Average daily shares traded1.6M793K
PRA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

IQV leads this category, winning 1 of 1 comparable metric.

Wall Street rates IQV as "Buy" and PRA as "Hold". Consensus price targets imply 26.3% upside for IQV (target: $226) vs -25.5% for PRA (target: $18).

MetricIQV logoIQVIQVIA Holdings In…PRA logoPRAProAssurance Corp…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$225.63$18.33
# AnalystsCovering analysts4411
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+4.1%0.0%
IQV leads this category, winning 1 of 1 comparable metric.
Key Takeaway

IQV leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). PRA leads in 2 (Total Returns, Risk & Volatility).

Best OverallIQVIA Holdings Inc. (IQV)Leads 4 of 6 categories
Loading custom metrics...

IQV vs PRA: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is IQV or PRA a better buy right now?

For growth investors, IQVIA Holdings Inc.

(IQV) is the stronger pick with 5. 9% revenue growth year-over-year, versus -2. 7% for ProAssurance Corporation (PRA). IQVIA Holdings Inc. (IQV) offers the better valuation at 22. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate IQVIA Holdings Inc. (IQV) a "Buy" — based on 44 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IQV or PRA?

On trailing P/E, IQVIA Holdings Inc.

(IQV) is the cheapest at 22. 8x versus ProAssurance Corporation at 24. 9x. On forward P/E, IQVIA Holdings Inc. is actually cheaper at 14. 1x.

03

Which is the better long-term investment — IQV or PRA?

Over the past 5 years, ProAssurance Corporation (PRA) delivered a total return of -3.

2%, compared to -23. 8% for IQVIA Holdings Inc. (IQV). Over 10 years, the gap is even starker: IQV returned +166. 5% versus PRA's -18. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IQV or PRA?

By beta (market sensitivity over 5 years), ProAssurance Corporation (PRA) is the lower-risk stock at 0.

05β versus IQVIA Holdings Inc. 's 1. 33β — meaning IQV is approximately 2675% more volatile than PRA relative to the S&P 500. On balance sheet safety, ProAssurance Corporation (PRA) carries a lower debt/equity ratio of 32% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — IQV or PRA?

By revenue growth (latest reported year), IQVIA Holdings Inc.

(IQV) is pulling ahead at 5. 9% versus -2. 7% for ProAssurance Corporation (PRA). On earnings-per-share growth, the picture is similar: IQVIA Holdings Inc. grew EPS 4. 7% year-over-year, compared to -3. 9% for ProAssurance Corporation. Over a 3-year CAGR, IQV leads at 4. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IQV or PRA?

IQVIA Holdings Inc.

(IQV) is the more profitable company, earning 8. 3% net margin versus 4. 6% for ProAssurance Corporation — meaning it keeps 8. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IQV leads at 14. 0% versus 6. 6% for PRA. At the gross margin level — before operating expenses — PRA leads at 39. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IQV or PRA more undervalued right now?

On forward earnings alone, IQVIA Holdings Inc.

(IQV) trades at 14. 1x forward P/E versus 21. 8x for ProAssurance Corporation — 7. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IQV: 26. 3% to $225. 63.

08

Which pays a better dividend — IQV or PRA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is IQV or PRA better for a retirement portfolio?

For long-horizon retirement investors, ProAssurance Corporation (PRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05)). Both have compounded well over 10 years (PRA: -18. 8%, IQV: +166. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IQV and PRA?

These companies operate in different sectors (IQV (Healthcare) and PRA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

IQV

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

PRA

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IQV and PRA on the metrics below

Revenue Growth>
%
(IQV: 8.4% · PRA: -2.0%)
Net Margin>
%
(IQV: 8.3% · PRA: 6.0%)
P/E Ratio<
x
(IQV: 22.8x · PRA: 24.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.